Sadick Research Group, LLC.

New York, New York 10075

1 studies enrolling now · 8 studies all time

What they study most

Acne Vulgaris, Atopic, Atopic Dermatitis, Cutaneous Neurofibroma, Dermatitis, Dermatitis, Atopic, Dermatologic Disease, Eczema, Eczema Atopic Dermatitis, Eczema, Atopic, Neurofibromatosis 1, Psoriasis

Studies at this site

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis — Recruiting now
• NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) — Completed
• Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) — Completed
• Study to Assess the Efficacy and Safety of Orismilast in Psoriasis — Completed
• A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis — Completed
• A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) — Completed
• An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris — Completed